Paclitaxel for treatment of advanced small cell lung cancer (SCLC): a retrospective study of 185 patients

BACKGROUND: Etoposide-/platinum-based chemotherapy is the standard first-line treatment for extensive-disease small cell lung cancer (SCLC), but responses are short-lived and subsequent options limited. Here, we present our experience with paclitaxel in advanced treatment lines. METHODS: We retrospe...

Descripción completa

Detalles Bibliográficos
Autores principales: von Eiff, Damian, Bozorgmehr, Farastuk, Chung, Inn, Bernhardt, Denise, Rieken, Stefan, Liersch, Stephan, Muley, Thomas, Kobinger, Sonja, Thomas, Michael, Christopoulos, Petros, Steins, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139030/
https://www.ncbi.nlm.nih.gov/pubmed/32274145
http://dx.doi.org/10.21037/jtd.2019.12.74

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139030/
https://www.ncbi.nlm.nih.gov/pubmed/32274145
http://dx.doi.org/10.21037/jtd.2019.12.74

Ejemplares similares